Similar incubation of NIC-treated HCC1806 breast cancer cells with SAT led to significant increase in gene expression of Cd137 (hCd137: 2.4 ± 0.46-fold, p ≤ 0.05; mCd137: 5.6 ± 1.2-fold, p ≤ 0.01), Tmem26 (hTmem26: 2.7 ± 0.3-fold, p ≤ 0.05; mTmem26: 5.4-fold, p ≤ 0.01), Il13 (hIl13: 2.6 ± 0.3-fold, p ≤ 0.05; mIl13: 1.7 ± 0.2-fold, p ≤ 0.05), Il10 (hIl10: 1.9 ± 0.2-fold, p ≤ 0.05; mIl10: 2.1 ± 0.3-fold, p ≤ 0.05), Il4 (hIl4: 2.8 ± 0.5-fold, p ≤ 0.05), and Cd163 (hCd163: 6.2 ± 1.2-fold, p ≤ 0.01; mCd163: 3.0 ± 0.4-fold, p ≤ 0.05) (Figure 4(e)). This evidence concerns the gene IL4 and breast cancer.